drugset / Trial / NCT02765633
Cangrelor Neonatal PK/PD and Safety Study
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the PK/PD and safety profile of cangrelor in neonatal participants at risk of thrombosis.
Timeline
- Start
- 2017-01-03
- Primary completion
- 2019-08-31
- Completion
- 2019-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cangrelor | Small molecule | 0.25 ug/kg | Other |
| Subject | Cangrelor | Small molecule | 0.5 ug/kg | Other |